Press Release: Oricula : Oricula Therapeutics Secures Intellectual Property and Takes First Step to Commercialize Medicine to Preserve Hearing Licensing Agreement with University of Washington

SEATTLE, April 9, 2014 /PRNewswire/ -- Oricula Therapeutics, LLC, a biotech company uniquely positioned to introduce medications to preserve hearing, announced that it has secured initial funding and licensed intellectual property from University of Washington. These represent key...